Skip to main content
Larimar Therapeutics, Inc. logo

Larimar Therapeutics, Inc. — Investor Relations & Filings

Ticker · LRMR ISIN · US98885E1038 LEI · 529900NCBZHTTJV6HX73 US Professional, scientific and technical activities
Open in API
Filings indexed 666 across all filing types
Latest filing 2014-06-18 Capital/Financing Update
Country US United States of America
Listing US LRMR

About Larimar Therapeutics, Inc.

https://larimartx.com/

Larimar Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company utilizes a proprietary intracellular delivery platform to design fusion proteins that deliver therapeutic molecules to targets within cells. Its lead product candidate, nomlabofusp (formerly CTI-1601), is a recombinant fusion protein being evaluated in a Phase 2 clinical program for the treatment of Friedreich's ataxia, a rare and progressive genetic disease. Larimar Therapeutics plans to leverage its platform to develop additional therapies for other rare diseases characterized by deficiencies in intracellular proteins.

Recent filings

Filing Released Lang Actions
S-1MEF
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes details about the registrant, offering size, and signatures but does not contain financial statements or performance data. This type of filing is related to capital raising activities and financing. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 7312 characters, which is substantive and not merely an announcement or certification. Hence, the classification is CAP with high confidence.
2014-06-18 English
FORM 3 SUBMISSION
Director's Dealing
2014-06-18 English
FORM 3 SUBMISSION
Director's Dealing
2014-06-18 English
FORM 3 SUBMISSION
Director's Dealing
2014-06-18 English
FORM 3 SUBMISSION
Director's Dealing
2014-06-18 English
FORM 3 SUBMISSION
Director's Dealing
2014-06-18 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.